Palatin Technologies, Inc. ("Palatin" or the "Company"), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the closing of its previously...

Related Keywords

United States , New York , American , , Securities Exchange , Exchange Commission , Prnewswire Palatin Technologies Inc , Palatin Technologies Inc , Hc Wainwright Co , Announces Closing , Registered Direct , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act ,